After antigen capture, dendritic cells (DC) migrate into T cell-rich areas of secondary lymphoid organs, where they induce T cell activation, that subsequently drives B cell activation. Here, we investigate whether DC, generated in vitro, can directly modulate B cell responses, using CD40L-transfected L cells as surrogate activated T cells. DC, through the production of soluble mediators, stimulated by 3-to 6-fold the proliferation and subsequent recovery of B cells. Furthermore, after CD40 ligation, DC enhanced by 30-300-fold the secretion of IgG and IgA by sIgD Ϫ B cells (essentially memory B cells). In the presence of DC, naive sIgD ϩ B cells produced, in response to interleukin-2, large amounts of IgM. Thus, in addition to activating naive T cells in the extrafollicular areas of secondary lymphoid organs, DC may directly modulate B cell growth and differentiation.
A t the antigen/pathogen port of entry (e.g., mucosa, epidermis), dendritic cells (DC) 1 , such as Langerhans cells (LC), capture the antigen and then migrate via the afferent lymphatics into the T cell-rich areas of regional lymph nodes, where they are called interdigitating dendritic cells (IDC) (for review see reference 1). There, they present processed antigen to naive T cells and generate an antigen-specific primary T cell response. Once primed by DC, T cells can promote B cell activation, both by releasing T cell-derived cytokines such as IL-2, IL-4, and IL-5, and by direct intercellular contacts (for review see reference 2). Among the signals involved in T/B cell cooperation, the interaction between CD40 (on B lymphocytes) and its ligand (CD40L) expressed on activated T cells, appears to be of critical importance (for review see reference 3). CD40, a molecule related to the TNF receptor family, is expressed on multiple cell types, including mature B cells and bone marrowderived DC (4) . Cross-linking of CD40 promotes B cell survival (5) proliferation (6) as well as B cell differentiation and immunoglobulin class switching (7, 8) . The ligand for CD40, CD40L, is a TNF family member expressed on activated but not resting T cells (9) . The importance of CD40/CD40L pathway in B cell immunopoiesis has been demonstrated in vivo in patients with X-linked hyper IgM syndrome (for review see reference 10) .
The role of DC in humoral responses has been documented in vitro (11) and in vivo (12) (13) (14) (15) . Notably, DC incubated in vitro with antigen can induce, upon reinjection into mice, a protective humoral response (15) . The critical role of DC in induction of humoral responses is viewed as a consequence of T cell priming, required for cognate interaction between T cells and B cells. However, as the primary B cell activation occurs within the extrafollicular T cell-rich areas (16), we wondered whether, in addition to priming T cells, DC were able to interact directly with B cells. Accordingly, we set up a system in which a CD40L-transfected murine cell line (CD40L L cells) was used as surrogate activated T cells, to study the effects of DC on B cell activation. Recent studies have indicated the possibility of generating large numbers of DC in vitro starting either from unseparated blood or bone marrow populations or from purified CD34 ϩ hematopoietic progenitors (17) . DC, generated by culturing human CD34 ϩ hematopoietic progenitors with GM-CSF and TNF ␣ have been shown earlier to induce a strong proliferation of allogeneic T cells (18, 19) and to express a functional CD40, the triggering of which induces their maturation into cells with characteristics of IDC (20) . These in vitro-generated DC have been shown to contain LC as well as other DC related to dermal DC and thus were termed dendritic-Langerhans cells (D-Lc) (21) .
Here, we demonstrate that D-Lc can strongly enhance both proliferation and Ig production of CD40-activated naive and memory B cells. These results suggest that DC might directly be involved in the extrafollicular plasma cell formation during induction of primary naive B cell responses or reactivation of secondary memory B cell responses.
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Materials and Methods
Reagents and Cell Lines. Cultures of CD34 ϩ progenitors were established in RPMI-1640 (GIBCO BRL, Gaithersberg, MD) supplemented with 10% (vol/vol) FCS, 10 mM Hepes, 2 mM l -glutamine, 5 ϫ 10 Ϫ 2 M 2-mercaptoethanol, and 0.08 g/ml gentamycine (gentalline; Schering Plough, Levallois Perret, France), which will be referred to as complete RPMI. Cultures of B lymphocytes were carried out in modified Iscove's medium, supplemented with 10% inactivated FCS (MultiSer, Castell Hill, NSW), 2 mM l -glutamine (GIBCO BRL, Gaithersberg, MD) and 0.08 g/ml gentamycine. The murine CD40 L-transfected cell line (CD40L L cells) was produced in the laboratory as described earlier (22) and used as stimulator of B cell proliferation and differentiation. Mouse fibroblastic L cells stably transfected with the human CD32/Fc ␥ RII have been previously described (23) . A chimeric fusion protein between the mouse CD8-␣ and the human CD40 T cell ligand was constructed in our laboratory as previously reported (22) and produced in COS cells.
rhGM-CSF (specific activity: 2 ϫ 10 6 U/mg; Schering Plough Research Institute, Kenilworth, NJ) was used at a saturating concentration of 100 ng/ml (200 U/ml). rhTNF-␣ (specific activity, 2 ϫ 10 6 U/mg; Genzyme, Boston, MA) was used at an optimal concentration of 2.5 ng/ml (50 U/ml). Purified rhIL-2 (5 ϫ 10 4 U/mg) from Amgen (Thousand Oaks, CA) was used at 20 U/ml. Purified rhIL-4 and rhIL-10 (10 7 U/mg each; Schering Plough Research Institute, Kenilworth NJ) were used at 50 U/ml and 20 ng/ml, respectively.
Generation of D-Lc. Umbilical cord blood samples were obtained according to institutional guidelines. Cells bearing CD34 antigen were isolated from mononuclear fractions through positive selection, using anti-CD34 mAb (10 g/ml; Immu-133.3; Immunotech Marseille, France) and goat anti-mouse IgG-coated microbeads (Miltenyi Biotec GmBH, Bergish Gladbach, Germany). Isolation of CD34 ϩ progenitors was achieved using Minimacs separation columns (Miltenyi Biotec) (21) .
Cultures were established in the presence of GM-CSF and TNF-␣ in complete RPMI. CD34 ϩ cells were seeded for expansion in 24-well culture plates (Limbro, Flow Laboratories, McLean, VA) at 2 ϫ 10 4 cells/ml. Optimal conditions were maintained by splitting these cultures every 4-5 d. Cells were routinely collected at day 12 when the cultures contained between 70-90% of CD1a ϩ DC (18, 21) . These CD1a ϩ cells includes LC that express Birbeck granules as well as other DC and thus will be referred to as D-Lc throughout the text (21) . The CD1a Ϫ population includes granulocytes, monocytes, undifferentiated precursors and, in some instances, mature DC that have lost CD1a.
For certain experiments, after 12 d of culture in the presence of GM-CSF and TNF-␣ , cells generated from CD34 ϩ progenitors were collected and labeled with FITC-conjugated OKT6 (CD1a; Ortho Diagnostic). Cells were separated according to CD1a expression into CD1a Ϫ and CD1a ϩ fractions using a FACStar ® (Becton Dickinson, Mountain View, CA). The procedure of staining and sorting was performed in the presence of 5 mM EDTA in order to avoid cell aggregation. Reanalysis of the sorted populations showed a purity higher than 98%.
Isolation of Tonsillar B Cells. Mononuclear cells from tonsils were isolated by a standard Ficoll-HyPaque (dose ϭ 1,077 g/ml) gradient method. Tonsillar B cells were first enriched in the E Ϫ fraction and submitted to anti-CD2, anti-CD4, anti-CD8, anti-CD14, anti-CD16 mAb negative selection with magnetic beads coated with anti-mouse IgG (Dynabeads; Dynal, Oslo, Norway). In the isolated population, Ͼ 99% expressed CD19 and CD20 and Ͻ 1% expressed CD2 or CD14 antigens. Isolation of sIgD ϩ and sIgD Ϫ B cells subpopulations was performed using a preparative magnetic cell sorter (MACS; Becton Dickinson) (24) . IgD was expressed on Ͼ 99% of the sIgD ϩ B cell subpopulation and Ͻ 1% of sIgD Ϫ B cell subpopulation, as assessed by fluorescence analysis using a FACScan ® (Becton Dickinson). For certain experiments, sIgD Ϫ B cells were further separated according to CD38 and CD39 expression into CD38 ϩ CD39 Ϫ germinal center (GC) cells and CD38 Ϫ CD39 ϩ memory B cells using anti-CD38 and anti-CD39 mAbs and bead depletion as described earlier (25) .
In some experiments, total B cells were separated according to their size using a discontinuous gradient of Percoll (Pharmacia, Uppsala, Sweden) as described earlier (22) . B cells recovered at the interface of 35-55% layers were referred to as low density B cells, and cells recovered at the interface of 65-55% Percoll solutions were referred to as high density or resting B cells. In some cases, resting B cells were further labeled with FITC-conjugated anti-CD20, PEconjugated anti-CD38 (Becton Dickinson) and biotinylated antiIgD (Sigma), followed by incubation with Streptavidin-Tricolor (Kallestad, Austin, TX) and sorted into CD20 ϩ IgD ϩ CD38 Ϫ naive B cells and CD20 ϩ IgD Ϫ CD38 Ϫ memory B cells (25) . Reanalysis of the sorted populations showed a purity higher than 99%.
Isolation of Human Monocytes. Total PBMC were isolated from healthy donors by Ficoll-HyPaque centrifugation; monocytes were isolated by elutrial centrifugation as described elsewhere (26) . Control phenotype of the cultures was routinely performed using FITC-labeled anti-CD3 and anti-CD19 (Immunotech) and FITC-labeled IgG1 (Kallestad).
Giemsa and Immunostainings. Cells from cocultures of B cells and D-Lc over CD40L L cells were cytocentrifuged for 5 min at 500 rpm on microscope slides. Some slides were used for MayGrünwald-Giemsa staining and the others were fixed either in cold acetone or 4% paraformaldehyde during 10 min for immunocy-
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tology. Single stainings were performed using the alkaline phosphatase-anti-alkaline phosphatase system (APAAP technique) with mouse anti-HLA-DR (IgG1 from Immunotech) or anti-CD80 (IgG1 from Becton Dickinson) revealed by the Fast Red substrate (DAKO). Double stainings were performed using the biotin-avidin-peroxidase system (mouse IgG2a anti-HLA-DR from Becton Dickinson) and the APAAP technique (mouse IgG1 anti-CD20 from Becton Dickinson) as described elsewhere (30) . Peroxidase activity was developed by 3-amino-9-ethylcarbazole, which gives a red color, and alkaline phosphatase activity was developed by Fast Blue substrate, which gives a blue color.
Results

D-Lc Enhance the Growth of CD40-activated B Cells.
In early experiments, using allogeneic cord blood DC and resting tonsillar T cells and B cells, DC were found to induce the activation of T cells, subsequently resulting in the differentiation of B cells as measured by Ig production (Caux, C., B. Vanbervliet, and J. Banchereau, unpublished results). Accordingly, we wondered whether D-Lc generated in vitro by culturing cord blood CD34 ϩ cells for 12 d in the presence of GM-CSF and TNF-␣ (later on referred to as D-Lc) (18, 21) Fig. 1 A , left ) . Kinetics analysis shows that addition of 10 4 D-Lc to CD40 triggering resulted in a twofold increase of [ 3 H]TdR incorporation at day 2, which reached fourfold at day 4, when a plateau is reached (Fig. 1 B ) . This enhancement of B cell DNA synthesis by D-Lc is associated to an important increase in number of viable B cells (Fig. 1 C ) that reaches a plateau at day 10, a time when D-Lc increased B cell num- Fig. 2 A) . Addition of 10 4 D-Lc to CD40-activated B cells results in the production of microgram amounts of IgG (range, 4-70 g/ml; mean increase, 125; n ϭ 12) and IgA (range, 0.8-6 g/ml; mean increase, 33; n ϭ 12). In contrast, IgM secretion was increased only 5-to 15-fold (range, 0.5-2 g/ml; mean increase, 10; n ϭ 12). As few as 330 D-Lc induced an eightfold increase in total Ig secretion, maximal effect being obtained with 10 4 D-Lc per well (40-fold increase) (Fig. 2 B) .
Tonsillar B cells consist of naive B cells, expressing surface IgM and IgD as well as GC B cells and memory B cells that have mostly undergone isotype switch, thus resulting in a loss of IgD expression (28, 29) . Therefore, we analyzed whether either purified sIgD ϩ B cells (naive B cells) or sIgD Ϫ B cells (GC and memory B cells) were preferential targets for D-Lc effect on IgG and IgA secretions. As shown in Fig. 2 C, CD40-activated naive sIgD ϩ B cells did not produce IgG whether or not D-Lc are added. Separation of sIgD Ϫ B cells into CD38 ϩ CD39 Ϫ GC cells and CD38 Ϫ CD39 ϩ memory B cells (using mAbs and bead depletion) (25) , allowed identification of the responding cell population. As shown in Fig. 2 C, memory B cells represent the main source of IgG as, when cultured in the presence of D-Lc, 10 3 memory B cells produced 5 g/ml IgG and 10 4 27 g/ml, while GC cells produced Ͻ0.5 g/ml and 4 g/ml, respectively, under such culture conditions.
To exclude that these observations could be the result of expansion of in vivo-activated B cells, resting and activated B cells were separated according to their density by Percoll gradients. As shown in Table 1 eration, whereas CD1a Ϫ cells were ineffective (Fig. 4 Aa).
In addition, as few as 250 CD1a ϩ cells induced a 10-fold increase in IgG production, in absence of exogenous cytokines (Fig. 4 Ab), and in IgM production, in the presence of IL-2 (Fig. 4 Ac). In contrast, even at high cell density (10 4 cells), CD1a Ϫ cells remained ineffective in stimulating either IgG or IgM production, demonstrating that the described stimulatory effects of in vitro-generated D-Lc on B cells are restricted to CD1a ϩ D-Lc. Although highly purified B cells (Ͼ99% CD20 ϩ cells), isolated using either bead depletion or cell sorting (Table 1) , were used in all experiments, the presence of IL-2 and D-Lc, known for their strong capacity to stimulate alloreactive T cells, renders it necessary to exclude a possible contribution of potentially contaminating T cells. For that purpose, phenotype of cultured cells was performed routinely. As an example, Fig. 4 
D-Lc Are More Efficient than Monocytes in Enhancing CD40-induced B Cell Differentiation.
We compared the effects of various antigen-presenting cells including D-Lc, elutriated monocytes (Ͼ90% CD14), and lymphoblastoid cell lines (EBV-LCL) on the proliferation and differentiation of CD40-activated B cells. As shown in Fig. 5 A, monocytes were as potent as D-Lc in enhancing CD40-induced B cell proliferation, whereas EBV cell lines were totally inefficient (only one of the three tested is shown in Fig. 5 ). Significant IgG production, in absence of cytokine, was observed with 3.5 ϫ 10 2 -10 3 D-Lc, whereas more than 5 ϫ 10 3 monocytes were required to observe the same effects. At higher cell density (10 4 cells), monocytes induced levels of IgG in the order of 5 g/ml compared with 17 g/ml for D-Lc (Fig. 5 B) . Concerning the IL-2-dependent IgM production, a significant effect was observed with less than 450 D-Lc, whereas more than 2.5 ϫ 10 3 monocytes were required to reach similar levels of IgM secretion. Thus, whereas D-Lc and monocytes shared an equal ability to enhance B cell proliferation, D-Lc are more efficient that monocytes in inducing B cells to secrete IgG and IgM.
The Effect of D-Lc Can Be Obtained in the Presence of Soluble CD40L.
To analyze a possible contribution of the fibroblastic cell line (CD40L L cells), CD40 activation was carried out with a soluble form of CD40L using a fusion protein between the mouse CD8-␣ and the human CD40L. The soluble protein was a less efficient activator than the CD40L L cells (Fig. 6) , particularly for proliferation of B cells, probably reflecting differences in the mode of CD40 3 C). However, in IL-2 supplemented cultures, addition of D-Lc induced CD40-activated B cells to secrete high levels of IgM, which reached 50 g/ml (mean increase, 161-fold; n ϭ 16). Separation of B cells into sIgD ϩ and sIgD Ϫ B cells showed that production of IgM was mainly a property of the naive sIgD ϩ B cell population (Fig. 3 B) . Note, however, that sIgD Ϫ B cells can be induced to produce significant levels of IgM provided 10-fold more B cells (10 4 ) are added to cultures. In addition, results presented in Table 1 show that D-Lc can induce small resting naive B cells (high density sIgD ϩ CD38 Ϫ cells) to produce high amounts of IgM in the presence of CD40 triggering and IL-2. (Fig. 7 A) . Immunostainings on such cytospins showed large HLA-DR 2ϩ CD80 high cells with dendritic morphology surrounded by HLA-DR 2ϩ CD80 low B cells (Fig. 7, B and C) . Immunostainings using anti-CD3 mAb failed to detect any positive cells (data not shown). Double stainings definitely identifies CD40-activated B cells (CD20 ϩ /HLA-DR low ) in close contacts with D-Lc (CD20 Ϫ / HLA-DR high ), suggesting that these interactions may contribute to the D-Lc-dependent stimulation of B cell growth and differentiation described in this study.
Experiments were designed to determine whether the functions of D-Lc on B cells were mediated through soluble factors and/or cell-cell interactions and whether D-Lc engagement. Yet, addition of D-Lc resulted in enhanced B cell proliferation (Fig. 6 A) and differentiation (Fig. 6 B) . (Fig. 8 B) . However, IgM levels obtained were lower than those observed in direct contact coculture (6.1 Ϯ 0.8 g/ml versus 15.5 Ϯ 2.5 g/ml), suggesting that cellcell contacts may also contribute. Note that D-Lc do not deliver any signal when B cells are not activated ( Fig. 8 ; B plus CD32 L cells).
Thus, the effect of D-Lc on B cell proliferation appears to be mediated by soluble factor(s), the production of which is independent of CD40 engagement on the D-Lc. In contrast, the effect on B cell differentiation, also mediated through soluble mediator(s), requires CD40 ligation of the D-Lc.
Discussion
The present study demonstrates that DC can directly provide signals to CD40-activated B cells, leading to enhanced proliferation as well as differentiation. To our knowledge, this study represents the first study demonstrating a direct effect of DC on normal B lymphocytes. Such information represents an important complement to studies performed earlier with mouse B lymphocytes, pointing out the critical role of DC during the course of the humoral response, including the following: (a) the demonstration that clusters of helper T lymphocytes, histocompatible B cells, and DC represented the site in which antibody-producing cells develop during the response to thymus-dependent antigens in vitro (11) (16, 37, 38) ; (c) after antigenic challenge, CD40L-expressing T cells are mainly found within periarteriolar lymphatic sheaths (39) , thus indicating that CD40-dependent activation of DC may occur within the extrafollicular areas of secondary lymphoid organs; (d) the IL-2 requirement for naive B cells to produce IgM is consistent with immunohistochemical studies showing, after immunization, the colocalization of CD40L ϩ IL-2 producing CD4 ϩ T cells and specific antibody-secreting B cells in the extrafollicular areas of secondary lymphoid organs (39) (40) (41) . In keeping with this, in vitro studies have shown IL-2 to be an important factor of primary humoral response (42) (43) (44) . In particular, recently activated CD4 ϩ T cells generate effector T cells that secrete mainly IL-2 and induce B cells to secrete essentially IgM (44) .
The mechanisms by which D-Lc regulate B cell re- 
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Functions of Dendritic Cells on B Cells Together with the above considerations, our results emphasize the importance of a three-party cellular interaction, where DC allow the encounter and interaction of antigenspecific T cells with antigen-specific B cells during primary humoral responses. First, DC, homing into the T cell-rich areas, present processed antigen to naive T cells, through an MHC-TCR interaction, resulting in upregulation of CD40L on the T cell. In return, the activated T cell stimulates the DC through CD40, resulting in CD80 and CD86 upregulation and cytokine production (20) . Then, the triggering of CD28 on the T cell, in the presence of DC-derived cofactors induces a full T cell activation followed by IL-2 production. Second, these reciprocal DC-T cell interactions are likely to occur concomitantly with cognate T-B cell interactions. Antigen-specific B cells, through CD40 engagement and T cell-derived IL-2 differentiate into IgMsecreting plasma cells, after close contact with DC previously activated through CD40. There is presently no evidence that DC present unprocessed antigen to B lymphocytes directly, though it is tempting to speculate that they may use surface Fc receptors to carry the antigens in the form of immune complexes or use lectins such as DEC 205 (46) or the mannose receptor (47) to present unprocessed antigen to specific B cells.
As a conclusion, the present results demonstrate that DC can directly modulate CD40-dependent B cell activation, suggesting that the critical role of DC in initiation of T-dependent humoral response might be related to direct modulation of B cell responses in the extrafollicular areas of lymphoid organs. 
